J. Eichholz

发表

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

J. Chaft, N. Riaz, A. Rimner, 2023, JAMA network open.

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.

N. Schultz, A. Drilon, K. Yu, 2023, Lung cancer.

Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).

N. Schultz, K. Yu, D. Gomez, 2022, Journal of Clinical Oncology.

Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer

K. Aziz, A. Rimner, M. Offin, 2021, Translational Lung Cancer Research.

A Phase 1 Safety Study of Avelumab Plus Stereotactic Body Radiation Therapy in Malignant Pleural Mesothelioma

E. Yorke, M. Zauderer, V. Rusch, 2022, JTO clinical and research reports.

Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.

S. Digumarthy, A. Drilon, J. Donington, 2022, Journal of Thoracic Oncology.

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

N. Schultz, J. Reis-Filho, B. Mueller, 2023, Nature communications.

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

C. Rudin, M. Kris, J. Reis-Filho, 2023, Frontiers in oncology.